Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database

BACKGROUND: Polymyxin B hemoperfusion (PMX) removes endotoxin from septic shock patients. Although the treatment has been clinically used for more than 20 years, its cost-effectiveness has not been evaluated in detail. METHODS: This study used the Japanese diagnosis procedure combination (DPC) admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimori, Kenji, Tarasawa, Kunio, Fushimi, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245629/
https://www.ncbi.nlm.nih.gov/pubmed/37386542
http://dx.doi.org/10.1186/s44158-023-00087-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245629/
https://www.ncbi.nlm.nih.gov/pubmed/37386542
http://dx.doi.org/10.1186/s44158-023-00087-6

Ejemplares similares